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A Major Mycobacterium tuberculosis 
outbreak caused by one specific 
genotype in a low-incidence 
country: Exploring gene profile 
virulence explanations
Dorte Bek Folkvardsen1, Anders Norman1,2, Åse Bengård Andersen3,4, 
Erik Michael Rasmussen1, Troels Lillebaek1 & Lars Jelsbak  2
Denmark, a tuberculosis low burden country, still experiences significant active Mycobacterium 
tuberculosis (Mtb) transmission, especially with one specific genotype named Cluster 2/1112–15 (C2), 
the most prevalent lineage in Scandinavia. In addition to environmental factors, antibiotic resistance, 
and human genetics, there is increasing evidence that Mtb strain variation plays a role for the outcome 
of infection and disease. In this study, we explore the reasons for the success of the C2 genotype by 
analysing strain specific polymorphisms identified through whole genome sequencing of all C2 isolates 
identified in Denmark between 1992 and 2014 (n = 952), and the demographic distribution of C2. Of 
234 non-synonymous (NS) monomorphic SNPs found in C2 in comparison with Mtb reference strain 
H37Rv, 23 were in genes previously reported to be involved in Mtb virulence. Of these 23 SNPs, three 
were specific for C2 including a NS mutation in a gene associated with hyper-virulence. We show that 
the genotype is readily transmitted to different ethnicities and is also found outside Denmark. Our data 
suggest that strain specific virulence factor variations are important for the success of the C2 genotype. 
These factors, likely in combination with poor TB control, seem to be the main drivers of C2 success.
There is increasing evidence that, in addition to environmental factors1, drug resistance2 and human genetics3, 
strain variation in members of the Mycobacterium tuberculosis Complex (MTBC) plays a key role in the outcome 
of tuberculosis (TB) infection and disease4,5. Hence, there is a need to better understand the global diversity of 
MTBC in order to determine whether and how this diversity has relevance for TB control. Molecular epidemi-
ology studies have demonstrated a diverse Mycobacterium tuberculosis (Mtb) population structure but also the 
existence of specific dominant clonal lineages with epidemic behaviour. This implies that some strains may have 
acquired functional advantages (over others) in their ability to transmit and cause disease6. One explanation 
could be the increased transmission of Drug-Resistant TB7, which demonstrates the ability of the bacterium to 
adapt to antibiotic pressure. However, dominant lineages without resistance exist8, and the specific relationship 
between the genetic background of the different Mtb lineages and their clinical phenotypes remains far from 
understood9.
In Denmark, one specific clonal strain has increased dramatically. This outbreak strain, “Cluster 2/1112–15” 
(hereafter, just C2), was first identified in 1992 in 8 patients. Over the last 25 years, the strain has caused disease 
in more than 1000 individuals, and is now the predominant outbreak strain in Scandinavia. Additionally, in 2001, 
C2 was transmitted to Greenland, adding to an existing heavy TB burden in this region10.
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We have previously characterized the C2 outbreak using whole genome sequencing (WGS) on a sparse 
time-series consisting of 115 isolates (five from each of the years 1992–2014) and shown that it was a clonal out-
break belonging to MTBC lineage 4.8, with 2 discernible phylogenetic clades, a major and a minor, and a most 
common recent ancestor dating back to 1959 (95% CI 1944–1973), pointing to its introduction into Denmark 
sometime after the Second World War11. The closest known related strains were found to originate in Russia, but 
were separated from C2 by at least 200 years. Therefore, although the exact journey of C2 into Denmark remains 
elusive, our initial analysis raises the question, whether the current success of the C2 outbreak is attributable 
to a unique genetic virulence profile acquired prior to its introduction to Denmark. In order to investigate the 
potential biological backgrounds for the success of this Mtb strain, we extend our WGS analysis to all available 
C2 isolates identified between 1992 and 2014 to pinpoint all universally preserved mutations to allow a detailed 
analysis of all C2-specific polymorphisms. As the definition of virulence is still widely discussed, we use the terms 
virulence and success interchangeably.
Results
C2 in Denmark. We extended our WGS to include all C2 Mtb isolates identified in the Kingdom of Denmark 
from 1992 to 2014 through either Mycobacterial Interspersed Repetitive Units-Variable Number of Tandem 
Repeats (MIRU-VNTR) or Restriction Fragment Length Polymorphism (RFLP), respectively. Initially, this com-
prised 989 isolates, but this figure was later reduced to 952 isolates from 892 patients, due to 8 strains having 
first been misidentified as Cluster-2 or 1112–15, and 28 strains being excluded due to lack of growth (n = 12) or 
insufficient sequence coverage (n = 18). The C2 strains were found in patients with different nationalities and eth-
nicities (630 Danish-born (DB), 217 Greenlandic-born (GB) and 45 foreign-born (FB) (from Africa, Middle East, 
Asia and Europe, own data)). All Mtb strains had been susceptibility tested for the four standard drugs identifying 
only one strain resistant to isoniazid and another strain resistant to pyrazinamide. The median coverage of the 952 
strains was 39.9× [IQR: 28.5–57.6].
Genomic analysis of C2. Analysing the set of 952 isolates, we identified 1309 high quality SNPs, out of 
which 414 (Supplementary Table S1) were determined to be present in all C2 strains against the H37Rv back-
ground, hereafter referred to as monomorphic SNPs. The remaining 895 mutations arose during the C2 outbreak 
out of which 81 SNPs (9%) occurred in 5 or more strains. Of the 414 identified monomorphic SNPs, 234 (57%) 
were non-synonymous (NS), 133 (32%) were synonymous, and 47 (11%) were intergenic, corresponding to an 
overall dN/dS ratio of 0.64.
Of the 234 NS monomorphic SNPs, 58 were found in genes involved in cell wall and cell processes, 52 in genes 
involved in intermediary metabolism and respiration, 51 in conserved hypotheticals, 32 in genes involved in lipid 
metabolism, 16 in genes involved in information pathways, 11 in genes involved in virulence, detoxification or 
adaptation, 11 in genes involved in regulatory proteins, 2 in genes involved in insertion sequences and phages 
and 1 in a gene with unknown function. We found SNPs in 1–13% of the total numbers of genes in the different 
categories according to Tuberculist (Table 1). It is important to note that genes encoding enzymes important for 
cell wall and cell processes and intermediary metabolism and respiration are present with a high number of genes 
in Mtb12, we did however, find more SNPs in this category than expected (Table 1).
Universally conserved single-nucleotide polymorphisms in C2. Out of the 414 SNPs (Supplementary 
Table S1), 244 (59%) were universally conserved among reference strains from a global collection of MTBC 
strains13, meaning that these differences likely stem from mutations arising in the reference strain H37Rv, since 
the two MTBC lineages 4.8 and 4.9 diverged. Furthermore, 24 SNPs were previously identified as universally 
conserved among strains belonging to MTBC lineage 4.814 and 89 SNPs were also found to be conserved among 
the five strains from Samara, Russia (SAM5), previously identified as being more closely related to C2 than all 
other global strains from MTBC lineage 4.8 (Fig. 1A)11. Thus, 57 SNPs (14%) were uniquely conserved among 
C2 (26 synonymous, 26 non-synonymous and 5 intergenic). Accordingly, the dN/dS ratio decreased significantly, 
from 0.64 to 0.36, as more and more distantly related strains were removed from the analysis, resulting in much 
stronger purifying selection (Fig. 1B).
Functional group C2 SNPs TubercuList
% of genes we 
found SNPs Expecteda
Expected # of 
SNPsb
Information pathways 16 242 6,61 0,06 14,66
Cell wall and cell processes 58 772 7,51 0,20 46,76
Intermediary metabolism and respiration 52 936 5,56 0,24 56,70
Virulence, detoxification, adaptation 11 239 4,60 0,06 14,48
Conserved hypotheticals 51 1042 4,89 0,27 63,12
Regulatory proteins 11 198 5,56 0,05 11,99
Lipid metabolism 32 272 11,76 0,07 16,48
Insertion seqs and phages 2 147 1,36 0,04 8,90
Unknown 1 15 6,67 0,00 0,91
Table 1. SNPs in C2 distributed in different functional groups according to TubercuList. aNumber of genes in 
that category divided by number of genes in total, all according to TubercuList. bExpected times total number of 
SNPs in C2.
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Potential virulence factors. The NS monomorphic SNPs were used to investigate for potential virulence 
factors. This was done by searching the literature for association between any of the genes in which we found 
NS SNPs and virulence. Of the 234 NS monomorphic SNPs, 23 were found in genes previously described to be 
involved in Mtb virulence (Table 2). Out of the 57 SNPs conserved in C2, we found three non-synonymous muta-
tions in genes previously associated with virulence.
Discussion
In this study, we analysed a major cluster of Mtb isolates (C2) associated with a TB outbreak with significant 
ongoing Mtb transmission for universally conserved genetic traits. The outbreak was initially confined to the 
capital city Copenhagen, predominantly in the inner city among socially marginalized persons, but subsequently 
transmitted all around the Danish kingdom, including Greenland, and to neighbouring countries. Clinical TB 
is influenced by variability in the host’s genetic background, immune status, diet, social, and environmental fac-
tors15,16 but little is known about the bacterial factors, especially genetic diversity in bacterial virulence factors that 
contribute to variable host responses.
The lifetime risk of developing active TB, when infected latently with Mtb is around 12%17. The reasons why 
some are more prone to develop TB, has been discussed widely, and a number of risk factors, such as HIV infec-
tion and immunosuppression, social factors, incarceration, or being a drug abuser, have been described18. Human 
genetic variation has also been suggested to play a role in success of TB3,19. The success of C2, however, does not 
seem to be strongly influenced by human genetic factors, as it is found in Denmark among different nationalities 
and ethnicities as diverse as ethnic Danes and ethnic Greenlanders.
It is likely that the main contributor to the success of the C2 strain is a lack of TB control and social problems, 
as is reported from other settings8. However, in Greenland, a total of 80 different MIRU-VNTR genotypes have 
been observed between 1992 and 2014. Of these, only 30 clusters with at least one other strain, and only 13 of 
these clusters have been seen in more than 10 patients, 3 of which are more abundant than C2. The most frequent 
of these, was found primarily in a remote setting in East Greenland20, and was therefore excluded from this 
comparison. In 2001, C2 was introduced and is spreading successfully in Greenland, a country already fighting 
an existing heavy TB-burden, suggesting that this particular strain, as well as the GC2 subtype21, may have some 
advantage over the many subtypes introduced in the same period (Fig. 2A). The majority of the C2 cases from 
Figure 1. Distribution and overall selective pressure of monomorphic SNPs conserved in 952 isolates of the 
M.tb DKC2 outbreak. (A) Maximum clade credibility phylogeny inferred from 2414 SNPs on 10 representative 
genomes from a global MTBC collection13, five related genomes from Samara, Russia (SAM5)34 and four 
representative strains from the DKC2 outbreak using BEAST with a fixed molecular clock (5.0 × 10−8 SNPs/
genome position/year) and a Bayesian Skyline population model. Green colored branches indicate the 
phylogenetic path that SNPs accumulated prior to the DKC2 outbreak have followed, while the yellow branch 
are monomorphic SNPs that have instead been accumulated in the H37Rv reference strain. Number of 
monomorphic SNPs per branch (Total SNPs/Non-synonymous SNPs) are displayed on respective branches. 
Numbers in parenthesis indicate distribution of non-synonymous SNPs in 23 genes previously associated with 
M.tb virulence. (B) Median effective population size (Ne) derived from Bayesian skyline plot (blue line – 95% 
HPD range is indicated with stippled lines) and the calculated dN/dS ratio of monomorphic SNPs accumulated 
in the DKC2 clade from specific time points.
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Greenland belonged to the major-lineage subgroup A.1 (50/53, Fig. 2B) and between 2004 and 2014, there has 
been 2–8 cases a year in this small country, approximately the same number of cases as a historically big cluster 
in Greenland, the C122,23 (Fig. 2A). As the vast majority of these cases belong to the same subgroup (Fig. 2B) it is 
Position Variant Locus
NT 
change
Lineage in which 
SNPs arose
AA 
change Annotation
Functional 
category Reference
55553 C- > T ponA1 (Rv0050) C1891T H37Rv P631S
Probable bifunctional penicillin-
binding protein 1 A/1B PonA1 (murein 
polymerase) (PBP1): penicillin-insensitive 
transglycosylase (peptidoglycan 
TGASE) + penicillin-sensitive 
transpeptidase (DD-transpeptidase)
cell wall and cell 
processes
Kieser PLOS 
Pathogens 201550
206339 T- > C mce1F (Rv0174) T1109C L4.9 L370P Mce-family protein Mce1F
virulence, 
detoxification, 
adaptation
Mikheecheva 
GBE 201735
290633 T- > G htdX (Rv0241c) A23C SAM5 K8Q Probable 3-hydroxyacyl-thioester dehydratase HtdX
intermediary 
metabolism and 
respiration
Gurvitz Journal 
of Bacteriology 
200951
686972 T- > C mce2A (Rv0589) T152C L4.9 F51S Mce-family protein Mce2A
virulence, 
detoxification, 
adaptation
Mikheecheva 
GBE 201735
755122 C- > T mazE2 (Rv0660c) G105A C2 R35H Possible antitoxin MazE2
virulence, 
detoxification, 
adaptation
Maisonneuve 
PNAS 201132
775639 T- > C mmpL5 (Rv0676c) A2843G H37Rv I948V Probable conserved transmembrane transport protein MmpL5
cell wall and cell 
processes
Wells PLOS 
Pathogens 201352
852910 C- > T phoR (Rv0758) C515T H37Rv P172L Possible two component system response sensor kinase membrane associated PhoR regulatory proteins
Mikheecheva 
GBE 201735
1037911 C- > T pstA1 (Rv0930) C913T H37Rv R305* Probable phosphate-transport integral membrane ABC transporter PstA1
cell wall and cell 
processes
Mikheecheva 
GBE 201735
1100234 T- > C pepD (Rv0983) T1169C H37Rv L390P Probable serine protease PepD (serine proteinase) (MTB32B)
intermediary 
metabolism and 
respiration
Mikheecheva 
GBE 201735
2211477 G- > C mce3B (Rv1967) G877C SAM5 D293H Mce-family protein Mce3B
virulence, 
detoxification, 
adaptation
Mikheecheva 
GBE 201735
2216443 C- > A mce3F (Rv1971) C1187A L4.9 A396E Mce-family protein Mce3F
virulence, 
detoxification, 
adaptation
Mikheecheva 
GBE 201735
2507254 G- > A ptpA (Rv2234) G109A L4.8 A37T
Phosphotyrosine protein phosphatase PtpA 
(protein-tyrosine-phosphatase) (PTPase) 
(LMW phosphatase)
regulatory proteins Mikheecheva GBE 201735
2868793 C- > T vapB19 (Rv2547) C188T SAM5 T63I Possible antitoxin VapB19
virulence, 
detoxification, 
adaptation
Mikheecheva 
GBE 201735
3137058 G- > A vapB22 (Rv2830c) C168T L4.9 A56V Possible antitoxin VapB22
virulence, 
detoxification, 
adaptation
Mikheecheva 
GBE 201735
3292720 T- > C pks1 (Rv2946c) A3635G SAM5 K1212E Probable polyketide synthase Pks1 lipid metabolism Mikheecheva GBE 201735
3293677 G- > C pks1 (Rv2946c) C2678G C2 L893V Probable polyketide synthase Pks1 lipid metabolism Mikheecheva GBE 201735
3296843 A- > G pks15 (Rv2947c) T999C H37Rv V333A Probable polyketide synthase Pks15 lipid metabolism
Gautam 
Infectious 
Diseases 201753
3453123 G- > A Rv3087 G199A C2 G67S Possible triacylglycerol synthase (diacylglycerol acyltransferase) lipid metabolism
Mikheecheva 
GBE 201735
3518555 A- > G nuoG (Rv3151) A1810G L4.9 T604A
Probable NADH dehydrogenase I (chain G) 
NuoG (NADH-ubiquinone oxidoreductase 
chain G)
intermediary 
metabolism and 
respiration
Mikheecheva 
GBE 201735
3826684 C- > T vapC47 (Rv3408) C137T H37Rv S46L Possible toxin VapC47. Contains PIN domain.
virulence, 
detoxification, 
adaptation
Mikheecheva 
GBE 201735
4055801 G- > A espA (Rv3616c) C576T L4.9 T192I ESX-1 secretion-associated protein A, EspA cell wall and cell processes
Mikheecheva 
GBE 201735
4210274 A- > G tcrY (Rv3764c) T737C L4.9 C246R Possible two component sensor kinase TcrY regulatory proteins
Parish Infection 
and Immunity 
200239, 
Bhattacharya 
Biochimie 201038
4288850 C- > T mmpL8 (Rv3823c) G2681A SAM5 V894M Conserved integral membrane transport protein MmpL8
cell wall and cell 
processes
Mikheecheva 
GBE 201735
Table 2. List of virulence associated monomorphic SNPs in C2.
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a clear indication that C2 in Greenland stems from a single rather than several independent introductions of the 
strain.
The previously reported C2 mutation-rate of 0.24 SNPs/genome/year11 correlates well with previous find-
ings24–26 and is in fact lower than some other findings27,28, indicating that the success of C2 is unlikely to have been 
caused by hypermutation. It has previously been reported that lineage 4 has a lower mutation-rate than lineage 
25, which in several studies reported as the most frequent20,25,27,29. Furthermore, as lineage 4 is not as prone to 
resistance as the Beijing lineage, some other factors must contribute to its worldwide success.
The overall dN/dS ratio of 0.64 also correlates well with previous findings8,30 and does not seem to suggest pos-
itive selection prior to the introduction of C2 into Denmark. In fact, there was a clear trend towards strong puri-
fying selection (decrease in dN/dS ratio) over the last thousand years (Fig. 1B). This is most likely, as suggested by 
Pepperell et al., attributable to explosive growth in the human population size over this period31.
SNPs were found in all categories of functional genes. Most were found in genes involved in cell wall and 
cell processes and intermediary metabolism and respiration, which is in accordance with these categories being 
the most frequent12, however, we did find more SNPs than expected. High-throughput sequencing has yielded 
functional genomic data for many organisms, but a large proportion of the genes are labelled “hypotheticals” or 
“unknown”. For Mtb, it is the case for 27% percent of the genes (1057/3863)12 and it is speculated if better under-
standing of these genes might lead to a better understanding of virulence. We found 53 monomorphic NS SNPs 
in these undescribed genes. Even though it is less than the 68 expected (Table 1), until a better understanding of 
these genes is obtained, we can only speculate if they have a role in the success.
When searching the literature for virulence linked to certain genes, we could find reports of virulence for 23 
of the genes with NS monomorphic SNPs seen in C2. Three of these SNPs, were found exclusively in C2 (Table 2). 
Examples include the mazE2 gene, a toxin-antitoxin (TA) gene, reported to help with inducing dormancy and 
persistence of the bacteria32. Another example is the pks1/15 gene, where an intact gene is reported to contrib-
ute to virulence by suppressing the human innate immune response33. Another 4 of the 23 SNPs reported to be 
involved in virulence, were found only in C2 and in the closest relative, the SAM5 group11,34 (Table 2). Among 
these are the MCE family proteins that play a role in adhesion and invasion of and survival inside macrophages35. 
Furthermore, when cloned into a non-pathogenic strain of E. coli, they gave E. coli the ability to enter and survive 
in mammalian cells, including macrophages36,37.
We also observed a monomorphic SNP in the tcrY gene. Interestingly, an additional mutation in this gene is 
found among the 81 most abundant SNPs observed within the C2 outbreak. In fact, this mutation is present in 
844 out of 864 (98%) of all C2 major lineage strains, and could therefore be a contributing factor to the much 
higher number of strains in the major- than in the minor lineage (85 strains). Mtb holds 12 two component 
regulatory systems that enables the bacteria to respond to different external stress indicators, the tcrXY system is 
one of these and has been suggested to be involved in regulating the genes required for suppressing intracellular 
growth38. Knockout of this gene has resulted in increased virulence in and shorter survival time for SCID mice39.
The present study holds a number of limitations. As previously mentioned, a consensus of the definition of 
virulence has not been obtained and we here use the term interchangeably with “success”. In our literature search 
we looked for studies that link certain genes with virulence, not genes that are in the functional category “vir-
ulence” (Table 2). One approach to experimentally test for virulence, is to measure growth, either in vitro or in 
vivo40. This is outside the scope of this study. Furthermore, it has been suggested that repetitive regions, such as 
pe-, ppe-, pe_pgrs-genes holds a key to understanding virulence of Mtb41,42 and in this analysis, these areas have 
been omitted due to difficulties with sequencing them by the method used. This limitation could be overcome in 
the future by using long-read sequencing, such as PacBio or Oxford Nanopore MinION.
In conclusion, our data show that the success of C2 cannot be readily attributed to acquisition of antibiotic 
resistance or demographic factors, such as nationalities and ethnicities. We suggest that bacterial genetic factors 
(such as polymorphisms in genes related to virulence), likely in combination with poor TB control, are the main 
contributors to the success of C2. Our identification of C2 specific polymorphisms in genes related to virulence 
constitute a valuable basis for studying Mtb virulence, and our results facilitate comparative studies as more 
sequencing data sets from outbreak strains becomes available.
Materials and Methods
Study population. Over the study period, 1992–2014, the incidence of TB in Denmark ranged from 6–12 
(7.1 in 2014) per 100,00043–45. In this period, a total of 9,501 Danish TB cases were culture-positive, from which 
94% had at least one Mtb isolate successfully genotyped, by RFLP until 2006 or by MIRU-VNTR after 2006. Out 
of all typed isolates, 61% clustered with other cases [2,415 DB; 396 GB; 2,653 FB], and 39% remained un-clustered 
[972 DB; 41 GB; 2481 FB]. Isolates from 989 cases [694 DB; 240 GB; 55 FB] were assigned to the C2 outbreak 
with either IS6110-RFLP or MIRU-VNTR typing, comprising 18% of all clustered Danish cases over the 23-year 
sampling period.
Initial processing of strains. All culture positive strains at the International Reference Laboratory of 
Mycobacteriology (IRLM), a biosafety level 3 (BSL-3) certified laboratory, are subjected to testing of antimicro-
bial resistance and genotyping. Genotypic susceptibility testing was initially done with a Line Probe Assay from 
Hain (Nehren, Germany), testing for rifampicin (RMP) and isoniazid (INH). Phenotypic drug susceptibility test-
ing was done by sub-culturing in Dubos medium with 0.045% tween 80 (SSI Diagnostika, Hilleroed, Denmark) 
and incubating at 37 °C. After 2 weeks of incubation, 100 µL of positive culture media was inoculated on a blood 
agar plate incubated at 35 °C and was checked for growth of other microorganism after 48 hours and microscopy 
was performed. If no contaminants were found, 500 µL were transferred to a MGIT tube, and after 2–3 days, 
when positive, the bacterial concentrations in liquid media were adjusted to equal densities at 580 nm by adding 
Dubos-Tween. One mL of positive broth was diluted in 4 mL of sterile saline and 0.5 mL was used for each drug 
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containing tube. For the growth control (GC) tube in INH, RMP, and EMB test 0.5 mL of 1:100 dilution was used. 
For the GC tube in PZA test 0.5 mL of 1:10 dilution was used. All drugs were provided by the manufacturer and 
used in the concentrations 0.1 mg/L for INH, 1.0 mg/L for RMP, 5.0 mg/L for EMB and 100 mg/L for PZA.
Subtyping was done with RFLP as described elsewhere46 and MIRU-VNTR DNA extraction was performed 
directly from stock and MIRU-VNTR typing performed as described by Supply et al.47 with a commercial kit 
(Genoscreen, Lille, France) and processed with a 48-capillary ABI 3730 DNA Analyzer (Applied Biosystems, CA, 
USA). The MIRU-VNTR allele assignation was performed using GeneMapper software (Applied Biosystems, CA, 
USA) or BioNumerics (Applied Maths, Sint-Martens-Latem, Belgium).
WGS. DNA isolations on the first 200 isolates were done as previously described48 and subsequently, in order 
to sequence the remaining almost 800 isolates more quickly, as described by Votintseva et al.49. In brief, 1 mL 
of a culture enriched in MGIT was centrifuged at 13,000 RPM for 10 min., the supernatant removed and pellet 
resuspended in 400 µL water, heat inactivated at 95 °C for 15 min and sonicated 15 min at 65 °C. The supernatant 
was mixed with 1/10th volume 3 M sodium acetate and 2 volumes of ice-cold 96% EtOH, vortexed and incubated 
at −20 °C for 1 h. After centrifugation, the pellet was washed with 70% EtOH and subsequently air-dried and 
re-suspended in 50 µl Tris-EDTA (TE) buffer by heating. Supernatant was transferred to a plate and cleaned with 
AMPure XP beads according to protocol.
Library preparation and variant calling was performed as previously described11. High quality single nucleo-
tide polymorphism (SNP) positions were retained if at least one sample had at least four reads coverage in each 
direction and a SNP frequency of at least 85%. To robustly identify universally conserved and abundant SNPs 
in C2, we randomly subsampled 500 out of the 952 strains multiple times (n = 10) and only retained positions 
Figure 2. Distribution of the most frequent genotypes and of the C2 subgroups in Greenland. (A) Comparison 
of the number of cases among the three most frequent TB genotypes reported in Greenland 1992–2014. (B) 
Abundance of the different epidemic subgroups within the C2 genotype found in Greenland 2001–2014. 
Subgroup designations are from a previous article11.
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identified as universally conserved (monomorphic) or abundant (present in >4 samples) more than once. The 
presence of universally conserved- and abundant SNPs was then verified for all samples using less stringent cri-
teria (minimum read coverage of 3 and a minimum SNP frequency of 70%). The synonymous substitution rate 
per site to the non-synonymous substitution rate per site (dN/dS ratio) was calculated as previously described26.
All the genes in which we found monomorphic non-synonymous (NS) SNPs where used in a literature search, 
looking for reports of these genes being involved in virulence.
Data availability. The data generated during the current study are available in the EMBL-EBI European 
Nucleotide Archive (ENA) under study accession PRJEB20214. https://www.ebi.ac.uk/ena/data/view/
PRJEB20214
Ethical considerations. This study was approved by the Danish Data Protection Agency (Jnr. 2012-54-
0100). In accordance with Danish law, observational studies performed in Denmark do not need approval from 
the Medical Ethics Committee or written consent from subjects. All analyses are presented anonymously.
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